Giuliana Rizzuto

CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program

Fabio Guolo, Luana Fianchi, Paola Minetto et al. · Blood Cancer Journal · 2020 · 57 citations · Full text

Medicine, Hematology, Oncology +13

AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia

Elisabetta Todisco, Cristina Papayannidis, Nicola Fracchiolla et al. · Cancer · 2023 · 48 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience

Marta Castelli, Maria Caterina Micò, Anna Grassi et al. · Bone Marrow Transplantation · 2024 · 19 citations · Full text

Life Sciences, Hematology, Immunology +14

Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS

Thomas Cluzeau, Fabio Guolo, Edmond Chiche et al. · Blood Advances · 2024 · 15 citations · Full text

Medicine, Hematology, Oncology +13

Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation

Federico Lussana, Chiara F. Magnani, Stefania Galimberti et al. · Blood Cancer Journal · 2025 · 11 citations · Full text

Medicine, Hematology, Immunology +16